BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND TRIM24, O15164, 8805, ENSG00000122779, TIF1ALPHA, TF1A, TIF1A, hTIF1, Tif1a, TIF1, RNF82, PTC6
6 results:

  • 1. A novel role of TRIM28 B box domain in L1 retrotransposition and ORF2p-mediated cDNA synthesis.
    Du Q; Stow EC; LaCoste D; Freeman B; Baddoo M; Shareef AM; Miller KM; Belancio VP
    Nucleic Acids Res; 2023 May; 51(9):4429-4450. PubMed ID: 37070200
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. High expression of trim24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer.
    Zhang L; Chen H; Ding B; Jiang W
    J Ovarian Res; 2022 Feb; 15(1):19. PubMed ID: 35105347
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Paraneoplastic Dermatomyositis in a Patient with Metastatic Gastric Carcinoma.
    Pozharashka J; Dourmishev L; Rusinova D; Balabanova M; Miteva L
    Acta Dermatovenerol Croat; 2020 Aug; 28(2):120-122. PubMed ID: 32876041
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. trim24 aggravates the progression of ovarian cancer through negatively regulating FOXM1 level.
    Zhou HE; Pan SS; Han H
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10647-10656. PubMed ID: 31858531
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis.
    Oldroyd A; Sergeant JC; New P; McHugh NJ; Betteridge Z; Lamb JA; Ollier WE; Cooper RG; Chinoy H;
    Rheumatology (Oxford); 2019 Apr; 58(4):650-655. PubMed ID: 30535395
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Different classes of coactivators recognize distinct but overlapping binding sites on the estrogen receptor ligand binding domain.
    Eng FC; Barsalou A; Akutsu N; Mercier I; Zechel C; Mader S; White JH
    J Biol Chem; 1998 Oct; 273(43):28371-7. PubMed ID: 9774463
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.